- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06935500
Ureteroscope Caliber and Surgeon Stress
Ureteroscope Diameter Influence Surgeon Stress?
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Patients admitted to our clinic with ureteral calculi and scheduled for ureteroscopic lithotripsy were informed about the procedure, potential complications, and routine clinical protocol. Patients who consented to surgery subsequently received detailed information about the study, and written informed consent was obtained from those who agreed to participate.
Participants were randomly assigned in a 1:1 ratio to undergo ureteroscopy using either a 4.5-6.5 Fr semirigid ureteroscope or an 8-9.8 Fr semirigid ureteroscope. Randomization was performed using a computer-generated simple randomization sequence. Group allocation was concealed using sequentially numbered opaque sealed envelopes, which were opened immediately before the procedure.
All ureteroscopic procedures were performed according to standard institutional protocols. Intraoperative parameters, including operative duration, complications, double-J stent placement, failure to access the stone, and basket use, were recorded prospectively by the research team.
To evaluate the impact of ureteroscope caliber on surgical stress, the operating surgeon's stress level was assessed immediately before and after each procedure using the State-Trait Anxiety Inventory Form TX-1 (STAI-TX1).
Postoperatively, all patients underwent supine direct abdominal radiography on postoperative day one in accordance with routine clinical practice. Stone-free status was determined based on radiographic evaluation and recorded by the investigator. No modifications were made to standard perioperative care during the study period.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Aydın
-
Aydin, Aydın, Turkey (Türkiye), 09100
- Aydın State Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Presence of ureteral calculi
- Use of Ho:YAG laser in ureteric lithotripsy
- Patient's acceptance to participate in the study
Exclusion Criteria:
- Presence of active urinary tract infection
- Emergency operation of the patient
- Presence of bilateral ureteral calculi
- Patient refusal to participate in the study
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
4,5/6,5f URS
Group operated with 4.5/6.5f
ureteroscope
|
2 different sizes of ureteroscopes, 4.5/6.5f
and 8/9.8f, will be used in the study.
|
|
8/9,8f URS
Group operated with 8/9.8f ureteroscope
|
2 different sizes of ureteroscopes, 4.5/6.5f
and 8/9.8f, will be used in the study.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in STAI-TX1 Score (Postoperative - Preoperative)
Time Frame: Immediately before and immediately after the procedure
|
The State-Trait Anxiety Inventory (STAI), Form TX-1, is a validated instrument used to assess situational (state) anxiety. The STAI-TX1 consists of 20 items scored on a 4-point Likert scale, with total scores ranging from 20 to 80. Higher scores indicate greater levels of anxiety. In this study, the STAI-TX1 was administered immediately before and immediately after each procedure. A change score (ΔSTAI-TX1) was calculated by subtracting the preoperative score from the postoperative score (postoperative minus preoperative). Positive values (ΔSTAI-TX1 > 0) indicate an increase in anxiety, whereas values ≤ 0 indicate no increase or a decrease in anxiety. |
Immediately before and immediately after the procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The secondary objective of this study was to assess the surgeon's stress levels during the operation.
Time Frame: From enrollment to the end ofsurgery at 2 hours
|
The psychological stress experienced by the surgeon will be evaluated immediately before and immediately after the procedure using the six-item short-form of the State Scale of the Spielberger State-Trait Anxiety Inventory.
The lowest score that can be obtained from the scale is 6 and the highest score is 20.
High score indicates high anxiety.
|
From enrollment to the end ofsurgery at 2 hours
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: GÖKHAN ŞAHİN, Aydin Adnan Menderes University
Publications and helpful links
General Publications
- Jones KI, Amawi F, Bhalla A, Peacock O, Williams JP, Lund JN. Assessing surgeon stress when operating using heart rate variability and the State Trait Anxiety Inventory: will surgery be the death of us? Colorectal Dis. 2015 Apr;17(4):335-41. doi: 10.1111/codi.12844.
- Omar M, Dorrah M, Khalifa A, El Sherif E, Sayedahmed K, Ghazwani Y, Noureldin YA. Randomized comparison of 4.5/6 Fr versus 6/7.5 Fr ureteroscopes for laser lithotripsy of lower/middle ureteral calculi: towards optimization of efficacy and safety of semirigid ureteroscopy. World J Urol. 2022 Dec;40(12):3075-3081. doi: 10.1007/s00345-022-04173-2. Epub 2022 Oct 8.
- Uzun H, Akca N. Is the 4.5-F ureteroscope (Ultra-Thin) an alternative in the management of ureteric and renal pelvic stones? Arab J Urol. 2018 Jun 21;16(4):429-434. doi: 10.1016/j.aju.2018.04.006. eCollection 2018 Dec.
- Atis G, Arikan O, Gurbuz C, Yildirim A, Erol B, Pelit S, Ulus I, Caskurlu T. Comparison of different ureteroscope sizes in treating ureteral calculi in adult patients. Urology. 2013 Dec;82(6):1231-5. doi: 10.1016/j.urology.2013.07.021. Epub 2013 Sep 12.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- decision:14 protocol no: 2025/
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ureteral Stones
-
Lukas J HefermehlKantonsspital BadenRecruiting
-
Indiana Kidney Stone InstituteUniversity of Washington; VA Puget Sound Health Care SystemCompleted
-
Adva-TecUniversity of British ColumbiaCompletedUnilateral Ureteral Stone | Renal Stone Fragments ≤ 2mmCanada
-
United States Naval Medical Center, San DiegoUnknown
-
University of British ColumbiaPercutaneous Systems, Inc.Completed
-
Beni-Suef UniversityCompleted
-
Hasanuddin UniversityCompletedKidney Stones | Ureteral Stone | Ureteral StenosisIndonesia
-
JW PharmaceuticalCompletedUreteral StoneKorea, Republic of
-
University of Sao Paulo General HospitalCompleted
-
Mansoura UniversityUnknownUrolithiasis | Ureteral Stone
Clinical Trials on endoscopic ureteric lithotripsy
-
Mansoura UniversityUnknown
-
Erasme University HospitalCompletedPancreatitisBelgium, Italy
-
Cairo UniversityUnknown
-
The Cleveland ClinicCompleted
-
St. Luke's Clinical Hospital, RussiaRecruitingQuality of Life | Urolithiasis | Ureteral Double-J StentRussia
-
The Adelaide and Meath Hospital, incorporating...WithdrawnSepsis | Hydronephrosis | Ureteric CalculusIreland
-
University of Sao Paulo General HospitalBoston Scientific CorporationUnknownCholedocholithiasis | Common Bile Duct GallstonesBrazil
-
Mahidol UniversitySiriraj Hospital, Mahidol University, Bangkok, Thailand.Recruiting
-
Shockwave Medical, Inc.Massachusetts General Hospital; Yale University; IQVIA Pty LtdActive, not recruitingPeripheral Arterial DiseaseJapan